Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

NCT00814086 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

NETWORK

Sponsor class

Conditions

Chemotherapeutic Agent Toxicity
Endometrial Adenocarcinoma
Fallopian Tube Carcinoma
Gastrointestinal Complication
Malignant Ovarian Mixed Epithelial Tumor
Neurotoxicity Syndrome
Ovarian Brenner Tumor
Ovarian Clear Cell Cystadenocarcinoma
Ovarian Mucinous Cystadenocarcinoma
Ovarian Serous Cystadenocarcinoma
Primary Peritoneal Carcinoma
Stage II Ovarian Cancer
Stage III Ovarian Cancer
Stage IV Ovarian Cancer
Undifferentiated Ovarian Carcinoma

Interventions

DRUG: Paclitaxel
DRUG: Cisplatin

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]